Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Accumulated Expenses (2021 - 2022)

NovaBridge Biosciences (NBP) has disclosed Accumulated Expenses for 2 consecutive years, with $6.1 million as the latest value for Q4 2022.

  • Quarterly Accumulated Expenses fell 25.58% to $6.1 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $6.1 million through Dec 2022, down 25.58% year-over-year, with the annual reading at $6.3 million for FY2022, 23.27% down from the prior year.
  • Accumulated Expenses for Q4 2022 was $6.1 million at NovaBridge Biosciences, down from $8.2 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $8.2 million in Q4 2021, with the low at $6.1 million in Q4 2022.